Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial

Objective To test the effect of patient‐reported outcome (PRO)–based tele‐health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele‐health followup performed by rheumatologists or rheumatology nurses. Methods A total of 294 pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis care & research (2010) 2018-03, Vol.70 (3), p.353-360
Hauptverfasser: Thurah, Annette, Stengaard‐Pedersen, Kristian, Axelsen, Mette, Fredberg, Ulrich, Schougaard, Liv M. V., Hjollund, Niels H. I., Pfeiffer‐Jensen, Mogens, Laurberg, Trine B., Tarp, Ulrik, Lomborg, Kirsten, Maribo, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 360
container_issue 3
container_start_page 353
container_title Arthritis care & research (2010)
container_volume 70
creator Thurah, Annette
Stengaard‐Pedersen, Kristian
Axelsen, Mette
Fredberg, Ulrich
Schougaard, Liv M. V.
Hjollund, Niels H. I.
Pfeiffer‐Jensen, Mogens
Laurberg, Trine B.
Tarp, Ulrik
Lomborg, Kirsten
Maribo, Thomas
description Objective To test the effect of patient‐reported outcome (PRO)–based tele‐health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele‐health followup performed by rheumatologists or rheumatology nurses. Methods A total of 294 patients were randomized (1:1:1) to either PRO‐based tele‐health followup carried out by a nurse (PRO‐TN) or a rheumatologist (PRO‐TR), or conventional outpatient followup by physicians. The primary outcome was a change in the Disease Activity Score in 28 joints (DAS28) after week 52. Secondary outcomes were physical function, quality of life, and self‐efficacy. The noninferiority margin was a DAS28 score change of 0.6. Mean differences were estimated following per protocol, intent‐to‐treat (ITT), and multivariate imputation analysis. Results Overall, patients had low disease activity at baseline and end followup. Demographics and baseline characteristics were similar between groups. Noninferiority was established for the DAS28. In the ITT analysis, mean differences in the DAS28 score between PRO‐TR versus control were −0.10 (90% confidence interval [90% CI] −0.30, 0.13) and −0.19 (90% CI −0.41, 0.02) between PRO‐TN versus control. When including 1 yearly visit to the outpatient clinic, patients in PRO‐TN had mean ± SD 1.72 ± 1.03 visits/year, PRO‐TR had 1.75 ± 1.03 visits/year, and controls had 4.15 ± 1.0 visits/year. This included extra visits due to inflammatory flare. Conclusion Among RA patients with low disease activity or remission, a PRO‐based tele‐health followup for tight control of disease activity in RA can achieve similar disease control as conventional outpatient followup. The degree of disease control did not differ between patients seen by rheumatologists or rheumatology nurses.
doi_str_mv 10.1002/acr.23280
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1899793723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007908524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3880-ad4af97de7e7840ffd27fa6e94ece598c82efde065c61bdb23807a5596e6b96d3</originalsourceid><addsrcrecordid>eNp1kU1LXDEUhkNpqaIu_AMl0E1djCa5X0l3w_gxglCYTsFdyNycOJHcm2mSq0xX3XXb3-gvMeOoC8GzOefAcx4OvAgdUnJMCWEnqg3HrGCcfEC7jFZ0VNYV__g6l9c76CDGW5IrU7wQn9EO4xWledlF_-bg4OHv_ykol5b43Dvn74cV_pmCSnCzxsYHPLc3y4Qnvk_BO-wNPrURVAQ8bpO9s2mNbY9nSxg6lbzVeBzSMthk43c8gzi4FDdHCs9Ur31n_4B-kbk8zoNVbh99MspFOHjue-jX-dl8Mh1d_bi4nIyvRm3BORkpXSojGg0NNLwkxmjWGFWDKKGFSvCWMzAaSF21NV3oBSs4aVRViRrqhah1sYe-bb2r4H8PEJPsbGzBOdWDH6KkXIhGFA0rMvr1DXrrh9Dn7yQjpBGEV6zM1NGWaoOPMYCRq2A7FdaSErkJSOaA5FNAmf3ybBwWHehX8iWODJxsgXvrYP2-SY4ns63yEWT8nEk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007908524</pqid></control><display><type>article</type><title>Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Thurah, Annette ; Stengaard‐Pedersen, Kristian ; Axelsen, Mette ; Fredberg, Ulrich ; Schougaard, Liv M. V. ; Hjollund, Niels H. I. ; Pfeiffer‐Jensen, Mogens ; Laurberg, Trine B. ; Tarp, Ulrik ; Lomborg, Kirsten ; Maribo, Thomas</creator><creatorcontrib>Thurah, Annette ; Stengaard‐Pedersen, Kristian ; Axelsen, Mette ; Fredberg, Ulrich ; Schougaard, Liv M. V. ; Hjollund, Niels H. I. ; Pfeiffer‐Jensen, Mogens ; Laurberg, Trine B. ; Tarp, Ulrik ; Lomborg, Kirsten ; Maribo, Thomas</creatorcontrib><description>Objective To test the effect of patient‐reported outcome (PRO)–based tele‐health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele‐health followup performed by rheumatologists or rheumatology nurses. Methods A total of 294 patients were randomized (1:1:1) to either PRO‐based tele‐health followup carried out by a nurse (PRO‐TN) or a rheumatologist (PRO‐TR), or conventional outpatient followup by physicians. The primary outcome was a change in the Disease Activity Score in 28 joints (DAS28) after week 52. Secondary outcomes were physical function, quality of life, and self‐efficacy. The noninferiority margin was a DAS28 score change of 0.6. Mean differences were estimated following per protocol, intent‐to‐treat (ITT), and multivariate imputation analysis. Results Overall, patients had low disease activity at baseline and end followup. Demographics and baseline characteristics were similar between groups. Noninferiority was established for the DAS28. In the ITT analysis, mean differences in the DAS28 score between PRO‐TR versus control were −0.10 (90% confidence interval [90% CI] −0.30, 0.13) and −0.19 (90% CI −0.41, 0.02) between PRO‐TN versus control. When including 1 yearly visit to the outpatient clinic, patients in PRO‐TN had mean ± SD 1.72 ± 1.03 visits/year, PRO‐TR had 1.75 ± 1.03 visits/year, and controls had 4.15 ± 1.0 visits/year. This included extra visits due to inflammatory flare. Conclusion Among RA patients with low disease activity or remission, a PRO‐based tele‐health followup for tight control of disease activity in RA can achieve similar disease control as conventional outpatient followup. The degree of disease control did not differ between patients seen by rheumatologists or rheumatology nurses.</description><identifier>ISSN: 2151-464X</identifier><identifier>EISSN: 2151-4658</identifier><identifier>DOI: 10.1002/acr.23280</identifier><identifier>PMID: 28511288</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Aftercare - methods ; Aged ; Arthritis, Rheumatoid - diagnosis ; Arthritis, Rheumatoid - physiopathology ; Arthritis, Rheumatoid - psychology ; Arthritis, Rheumatoid - therapy ; Demography ; Denmark ; Disease control ; Female ; Health risk assessment ; Health Status ; Humans ; Inflammation ; Joint diseases ; Male ; Middle Aged ; Nurses ; Patient Reported Outcome Measures ; Quality of Life ; Remission ; Remission Induction ; Rheumatoid arthritis ; Rheumatologists ; Rheumatology ; Self Efficacy ; Severity of Illness Index ; Telemedicine - methods ; Time Factors ; Treatment Outcome</subject><ispartof>Arthritis care &amp; research (2010), 2018-03, Vol.70 (3), p.353-360</ispartof><rights>2017, American College of Rheumatology</rights><rights>2017, American College of Rheumatology.</rights><rights>2018 American College of Rheumatology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3880-ad4af97de7e7840ffd27fa6e94ece598c82efde065c61bdb23807a5596e6b96d3</citedby><cites>FETCH-LOGICAL-c3880-ad4af97de7e7840ffd27fa6e94ece598c82efde065c61bdb23807a5596e6b96d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Facr.23280$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Facr.23280$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28511288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thurah, Annette</creatorcontrib><creatorcontrib>Stengaard‐Pedersen, Kristian</creatorcontrib><creatorcontrib>Axelsen, Mette</creatorcontrib><creatorcontrib>Fredberg, Ulrich</creatorcontrib><creatorcontrib>Schougaard, Liv M. V.</creatorcontrib><creatorcontrib>Hjollund, Niels H. I.</creatorcontrib><creatorcontrib>Pfeiffer‐Jensen, Mogens</creatorcontrib><creatorcontrib>Laurberg, Trine B.</creatorcontrib><creatorcontrib>Tarp, Ulrik</creatorcontrib><creatorcontrib>Lomborg, Kirsten</creatorcontrib><creatorcontrib>Maribo, Thomas</creatorcontrib><title>Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial</title><title>Arthritis care &amp; research (2010)</title><addtitle>Arthritis Care Res (Hoboken)</addtitle><description>Objective To test the effect of patient‐reported outcome (PRO)–based tele‐health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele‐health followup performed by rheumatologists or rheumatology nurses. Methods A total of 294 patients were randomized (1:1:1) to either PRO‐based tele‐health followup carried out by a nurse (PRO‐TN) or a rheumatologist (PRO‐TR), or conventional outpatient followup by physicians. The primary outcome was a change in the Disease Activity Score in 28 joints (DAS28) after week 52. Secondary outcomes were physical function, quality of life, and self‐efficacy. The noninferiority margin was a DAS28 score change of 0.6. Mean differences were estimated following per protocol, intent‐to‐treat (ITT), and multivariate imputation analysis. Results Overall, patients had low disease activity at baseline and end followup. Demographics and baseline characteristics were similar between groups. Noninferiority was established for the DAS28. In the ITT analysis, mean differences in the DAS28 score between PRO‐TR versus control were −0.10 (90% confidence interval [90% CI] −0.30, 0.13) and −0.19 (90% CI −0.41, 0.02) between PRO‐TN versus control. When including 1 yearly visit to the outpatient clinic, patients in PRO‐TN had mean ± SD 1.72 ± 1.03 visits/year, PRO‐TR had 1.75 ± 1.03 visits/year, and controls had 4.15 ± 1.0 visits/year. This included extra visits due to inflammatory flare. Conclusion Among RA patients with low disease activity or remission, a PRO‐based tele‐health followup for tight control of disease activity in RA can achieve similar disease control as conventional outpatient followup. The degree of disease control did not differ between patients seen by rheumatologists or rheumatology nurses.</description><subject>Aftercare - methods</subject><subject>Aged</subject><subject>Arthritis, Rheumatoid - diagnosis</subject><subject>Arthritis, Rheumatoid - physiopathology</subject><subject>Arthritis, Rheumatoid - psychology</subject><subject>Arthritis, Rheumatoid - therapy</subject><subject>Demography</subject><subject>Denmark</subject><subject>Disease control</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Health Status</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Joint diseases</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nurses</subject><subject>Patient Reported Outcome Measures</subject><subject>Quality of Life</subject><subject>Remission</subject><subject>Remission Induction</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatologists</subject><subject>Rheumatology</subject><subject>Self Efficacy</subject><subject>Severity of Illness Index</subject><subject>Telemedicine - methods</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>2151-464X</issn><issn>2151-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1LXDEUhkNpqaIu_AMl0E1djCa5X0l3w_gxglCYTsFdyNycOJHcm2mSq0xX3XXb3-gvMeOoC8GzOefAcx4OvAgdUnJMCWEnqg3HrGCcfEC7jFZ0VNYV__g6l9c76CDGW5IrU7wQn9EO4xWledlF_-bg4OHv_ykol5b43Dvn74cV_pmCSnCzxsYHPLc3y4Qnvk_BO-wNPrURVAQ8bpO9s2mNbY9nSxg6lbzVeBzSMthk43c8gzi4FDdHCs9Ur31n_4B-kbk8zoNVbh99MspFOHjue-jX-dl8Mh1d_bi4nIyvRm3BORkpXSojGg0NNLwkxmjWGFWDKKGFSvCWMzAaSF21NV3oBSs4aVRViRrqhah1sYe-bb2r4H8PEJPsbGzBOdWDH6KkXIhGFA0rMvr1DXrrh9Dn7yQjpBGEV6zM1NGWaoOPMYCRq2A7FdaSErkJSOaA5FNAmf3ybBwWHehX8iWODJxsgXvrYP2-SY4ns63yEWT8nEk</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Thurah, Annette</creator><creator>Stengaard‐Pedersen, Kristian</creator><creator>Axelsen, Mette</creator><creator>Fredberg, Ulrich</creator><creator>Schougaard, Liv M. V.</creator><creator>Hjollund, Niels H. I.</creator><creator>Pfeiffer‐Jensen, Mogens</creator><creator>Laurberg, Trine B.</creator><creator>Tarp, Ulrik</creator><creator>Lomborg, Kirsten</creator><creator>Maribo, Thomas</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial</title><author>Thurah, Annette ; Stengaard‐Pedersen, Kristian ; Axelsen, Mette ; Fredberg, Ulrich ; Schougaard, Liv M. V. ; Hjollund, Niels H. I. ; Pfeiffer‐Jensen, Mogens ; Laurberg, Trine B. ; Tarp, Ulrik ; Lomborg, Kirsten ; Maribo, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3880-ad4af97de7e7840ffd27fa6e94ece598c82efde065c61bdb23807a5596e6b96d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aftercare - methods</topic><topic>Aged</topic><topic>Arthritis, Rheumatoid - diagnosis</topic><topic>Arthritis, Rheumatoid - physiopathology</topic><topic>Arthritis, Rheumatoid - psychology</topic><topic>Arthritis, Rheumatoid - therapy</topic><topic>Demography</topic><topic>Denmark</topic><topic>Disease control</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Health Status</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Joint diseases</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nurses</topic><topic>Patient Reported Outcome Measures</topic><topic>Quality of Life</topic><topic>Remission</topic><topic>Remission Induction</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatologists</topic><topic>Rheumatology</topic><topic>Self Efficacy</topic><topic>Severity of Illness Index</topic><topic>Telemedicine - methods</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thurah, Annette</creatorcontrib><creatorcontrib>Stengaard‐Pedersen, Kristian</creatorcontrib><creatorcontrib>Axelsen, Mette</creatorcontrib><creatorcontrib>Fredberg, Ulrich</creatorcontrib><creatorcontrib>Schougaard, Liv M. V.</creatorcontrib><creatorcontrib>Hjollund, Niels H. I.</creatorcontrib><creatorcontrib>Pfeiffer‐Jensen, Mogens</creatorcontrib><creatorcontrib>Laurberg, Trine B.</creatorcontrib><creatorcontrib>Tarp, Ulrik</creatorcontrib><creatorcontrib>Lomborg, Kirsten</creatorcontrib><creatorcontrib>Maribo, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Arthritis care &amp; research (2010)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thurah, Annette</au><au>Stengaard‐Pedersen, Kristian</au><au>Axelsen, Mette</au><au>Fredberg, Ulrich</au><au>Schougaard, Liv M. V.</au><au>Hjollund, Niels H. I.</au><au>Pfeiffer‐Jensen, Mogens</au><au>Laurberg, Trine B.</au><au>Tarp, Ulrik</au><au>Lomborg, Kirsten</au><au>Maribo, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial</atitle><jtitle>Arthritis care &amp; research (2010)</jtitle><addtitle>Arthritis Care Res (Hoboken)</addtitle><date>2018-03</date><risdate>2018</risdate><volume>70</volume><issue>3</issue><spage>353</spage><epage>360</epage><pages>353-360</pages><issn>2151-464X</issn><eissn>2151-4658</eissn><abstract>Objective To test the effect of patient‐reported outcome (PRO)–based tele‐health followup for tight control of disease activity in patients with rheumatoid arthritis (RA), and the differences between tele‐health followup performed by rheumatologists or rheumatology nurses. Methods A total of 294 patients were randomized (1:1:1) to either PRO‐based tele‐health followup carried out by a nurse (PRO‐TN) or a rheumatologist (PRO‐TR), or conventional outpatient followup by physicians. The primary outcome was a change in the Disease Activity Score in 28 joints (DAS28) after week 52. Secondary outcomes were physical function, quality of life, and self‐efficacy. The noninferiority margin was a DAS28 score change of 0.6. Mean differences were estimated following per protocol, intent‐to‐treat (ITT), and multivariate imputation analysis. Results Overall, patients had low disease activity at baseline and end followup. Demographics and baseline characteristics were similar between groups. Noninferiority was established for the DAS28. In the ITT analysis, mean differences in the DAS28 score between PRO‐TR versus control were −0.10 (90% confidence interval [90% CI] −0.30, 0.13) and −0.19 (90% CI −0.41, 0.02) between PRO‐TN versus control. When including 1 yearly visit to the outpatient clinic, patients in PRO‐TN had mean ± SD 1.72 ± 1.03 visits/year, PRO‐TR had 1.75 ± 1.03 visits/year, and controls had 4.15 ± 1.0 visits/year. This included extra visits due to inflammatory flare. Conclusion Among RA patients with low disease activity or remission, a PRO‐based tele‐health followup for tight control of disease activity in RA can achieve similar disease control as conventional outpatient followup. The degree of disease control did not differ between patients seen by rheumatologists or rheumatology nurses.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28511288</pmid><doi>10.1002/acr.23280</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2151-464X
ispartof Arthritis care & research (2010), 2018-03, Vol.70 (3), p.353-360
issn 2151-464X
2151-4658
language eng
recordid cdi_proquest_miscellaneous_1899793723
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Aftercare - methods
Aged
Arthritis, Rheumatoid - diagnosis
Arthritis, Rheumatoid - physiopathology
Arthritis, Rheumatoid - psychology
Arthritis, Rheumatoid - therapy
Demography
Denmark
Disease control
Female
Health risk assessment
Health Status
Humans
Inflammation
Joint diseases
Male
Middle Aged
Nurses
Patient Reported Outcome Measures
Quality of Life
Remission
Remission Induction
Rheumatoid arthritis
Rheumatologists
Rheumatology
Self Efficacy
Severity of Illness Index
Telemedicine - methods
Time Factors
Treatment Outcome
title Tele‐Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A35%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tele%E2%80%90Health%20Followup%20Strategy%20for%20Tight%20Control%20of%20Disease%20Activity%20in%20Rheumatoid%20Arthritis:%20Results%20of%20a%20Randomized%20Controlled%20Trial&rft.jtitle=Arthritis%20care%20&%20research%20(2010)&rft.au=Thurah,%20Annette&rft.date=2018-03&rft.volume=70&rft.issue=3&rft.spage=353&rft.epage=360&rft.pages=353-360&rft.issn=2151-464X&rft.eissn=2151-4658&rft_id=info:doi/10.1002/acr.23280&rft_dat=%3Cproquest_cross%3E2007908524%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007908524&rft_id=info:pmid/28511288&rfr_iscdi=true